GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
11.03
-0.14 (-1.25%)
At close: Apr 26, 2024, 3:59 PM
11.08
+0.05 (0.45%)
After-hours: Apr 26, 2024, 4:00 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $288.67 million as of April 26, 2024. Its market cap has increased by 19.98% in one year.
Market Cap
288.67M
Enterprise Value
275.71M
1-Year Change
19.98%
Ranking
Category
Stock Price
$11.03
Market Cap Chart
Since September 2, 2020, GeneDx Holdings's market cap has decreased from $448.40M to $288.67M, a decrease of -35.62%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 291.00M | -5.52% |
| Apr 24, 2024 | 308.00M | -1.47% |
| Apr 23, 2024 | 312.60M | 15.48% |
| Apr 22, 2024 | 270.70M | 7.76% |
| Apr 19, 2024 | 251.20M | 0.76% |
| Apr 18, 2024 | 249.30M | 4.01% |
| Apr 17, 2024 | 239.70M | -4.27% |
| Apr 16, 2024 | 250.40M | -2.72% |
| Apr 15, 2024 | 257.40M | 2.71% |
| Apr 12, 2024 | 250.60M | -14.03% |
| Apr 11, 2024 | 291.50M | -3.22% |
| Apr 10, 2024 | 301.20M | 6.66% |
| Apr 9, 2024 | 282.40M | 3.82% |
| Apr 8, 2024 | 272.00M | 4.49% |
| Apr 5, 2024 | 260.30M | 10.39% |
| Apr 4, 2024 | 235.80M | -4.22% |
| Apr 3, 2024 | 246.20M | 1.28% |
| Apr 2, 2024 | 243.10M | 3.31% |
| Apr 1, 2024 | 235.30M | -1.09% |
| Mar 28, 2024 | 237.90M | -3.49% |
| Mar 27, 2024 | 246.50M | 8.26% |
| Mar 26, 2024 | 227.70M | 3.08% |
| Mar 25, 2024 | 220.90M | -1.52% |
| Mar 22, 2024 | 224.30M | -6.23% |
| Mar 21, 2024 | 239.20M | 7.89% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viemed Healthcare | 311.38M |
| Atai Life Sciences | 310.47M |
| Procaps Group | 310.25M |
| MeiraGTx Holdings | 309.08M |
| TriSalus Life Sciences | 308.21M |
| Terns Pharmaceuticals | 307.10M |
| Nyxoah | 304.25M |
| Ocugen | 303.64M |